Across TCGA pan-cancer cohorts, RNU1-136P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RNU1-136P’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RNU1-136P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU1-136P is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA, BRCA, and KIRP are the cancer types where RNU1-136P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU1-136P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	All	−0.187	.008	5	view →
BRCA	All	IV	−1.260	.037	2	view →
KIRP	All	III,IV	−0.125	.040	2	view →
CHOL	All	All	+0.276	.006	1	view →
LUAD	All	All	+0.199	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: RNU1-136P RNA expression & survival · all RNU1-136P data types